Does SULBACTAM Cause Hepatic lesion? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hepatic lesion have been filed in association with SULBACTAM. This represents 6.9% of all adverse event reports for SULBACTAM.
9
Reports of Hepatic lesion with SULBACTAM
6.9%
of all SULBACTAM reports
9
Deaths
0
Hospitalizations
How Dangerous Is Hepatic lesion From SULBACTAM?
Of the 9 reports, 9 (100.0%) resulted in death.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SULBACTAM. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does SULBACTAM Cause?
Drug ineffective (25)
Foetal exposure during pregnancy (14)
Abdominal pain (11)
Cardiac arrest (11)
Tachycardia (11)
Nausea (10)
Stevens-johnson syndrome (10)
Abdominal distension (9)
Anuria (9)
Candida infection (9)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which SULBACTAM Alternatives Have Lower Hepatic lesion Risk?
SULBACTAM vs SULFACETAMIDE
SULBACTAM vs SULFADIAZINE
SULBACTAM vs SULFADIAZINE\TRIMETHOPRIM
SULBACTAM vs SULFAMETHOXAZOLE
SULBACTAM vs SULFAMETHOXAZOLE\TRIMETHOPRIM